Qilu Antibiotics passed US FDA inspection with no 483 observation

ABOUT US

图片名称

Qilu Antibiotics passed US FDA inspection with no 483 observation


Release time:

2018-08-16

Qilu Pharmaceutical announces that its subsidiary Qilu Antibiotics successfully passed the US FDA inspection with no 483 observation. The inspection commenced on August 8, 2018 and was completed on August 16, 2018.

Qilu Antibiotics is the world’s major supplier of Cephalosporin products with the capacity of 2000 tons/year. Products have been exported to more than 40 countries, including US, EU, Japan, Korea, etc.

齐鲁制药有限公司

Tel: +86-531-83127705831277048312770683127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Email:export@qilu-pharma.com


监督举报

亲爱的合作伙伴:

欢迎举报以下行为!

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话:0531-83126898/55820713/83126871

举报邮箱:qljc@qilu-pharma.com

收信地址:山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线